Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer
BackgroundOpioids are the primary analgesics for cancer pain. Recent clinical evidence suggests opioids may counteract the effect of immune checkpoint inhibition (ICI) immunotherapy, but the mechanism for this interaction is unknown. The following experiments study how opioids and immunotherapy modu...
Main Authors: | Joseph R. Scarpa, Giacomo Montagna, George Plitas, Amitabh Gulati, Gregory W. Fischer, Joshua S. Mincer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1267532/full |
Similar Items
-
Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
by: Huimei Yi, et al.
Published: (2021-05-01) -
Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer
by: Ji-Yeon Kim, et al.
Published: (2023-03-01) -
Breaking Barriers: The Promise and Challenges of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
by: Sawsan Sudqi Said, et al.
Published: (2024-02-01) -
The role of immune checkpoints in cardiovascular disease
by: Laura I. Yousif, et al.
Published: (2022-10-01) -
Immune Checkpoint in Glioblastoma: Promising and Challenging
by: Jing Huang, et al.
Published: (2017-05-01)